Phase 3: Delgocitinib improves chronic hand eczema in adolescents Contemporary Pediatrics Source link
Hand Eczema Market to Reach USD 29.2 Billion by 2035, Impelled by the Development of New and More Effective Treatments, Including Biologics, Corticosteroids, and Topical Therapies BioSpace Source link
Top in allergy/asthma: Asthma risk among children with rhinovirus; chronic hand eczema Healio Source link
Unmet needs in chronic hand eczema present clear demand for new treatments: GlobalData Express Pharma Source link